Replies to post #283588 on Avid Bioservices Inc (CDMO)

[eb0783]

This, along with Wook’s comment, is just one more of the myriad ways to be paid (or to receive benefit) for manufacturing somone’s product for them. Just like there are an ulimited number of ways to pay for building the next Avid III or IV. The percentages paid by each party, and conditions, and limitations in a final agreement are endless.

It was the PPHM was angling towards producing molecules for small startups at interesting prices but with production commitment if the molecule got somewhere. Allows PPHM to use there new Fast Batch Type change possibilities which in the Stainless Steel multi-use reactor worlds is a mess.

However, the below is not what Worsley said to Wook (and to me as I was standing beside him). [by the way Wookie, that was the 2015 AACR ;-)] What you say here is certainly right. What Worsley was saying is to get some percentage of future revenues that that molecule would produce, not 100% of the rights. We were discussing some alternatives that would work with smaller companies (ie short on cash) rather than just a straight cash deal.

I think no small startup in its right mind would let PPHM/Avid do such production and loose partial control over there molecule. Rights to there molecule, if such start-up holds the IP, is the only thing they have and is what BP normally wants to get its hands on for bread-crumbs.

[asmarterwookie]

It was a very quick conversation that was just touching on angles. Throwing ideas around. I'm sure the idea has been refined.

Thanks for the update.

wook